GIM 0915
Alternative Names: GIM-0915Latest Information Update: 25 Aug 2023
At a glance
- Originator Georgiamune
- Class Antineoplastics; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 22 Aug 2023 Preclinical trials in Cancer in USA (unspecified route) before August 2023 (Georgiamune pipeline, August 2023)